Celsion Corp (CLSN.OQ)

CLSN.OQ on NASDAQ Stock Exchange Capital Market

1.23USD
1:00pm EDT
Price Change (% chg)

$0.02 (+1.65%)
Prev Close
$1.21
Open
$1.24
Day's High
$1.24
Day's Low
$1.22
Volume
24,300
Avg. Vol
627,681
52-wk High
$9.43
52-wk Low
$0.75

CLSN.OQ

Chart for CLSN.OQ

About

Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical... (more)

Overall

Beta: 1.48
Market Cap (Mil.): $69.09
Shares Outstanding (Mil.): 57.10
Dividend: --
Yield (%): --

Financials

  CLSN.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.70 -- --
ROI: -69.04 -2.58 18.76
ROE: -97.35 -2.66 19.59
Search Stocks

BRIEF-Celsion up in premarket trading after comments

NEW YORK, April 23 - Celsion Corp : * Up 17 percent in premarket trading after comments

23 Apr 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$460.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks